RecruitingPhase III🇵🇱 PolandFemale onlyEN originalOvarian cancerMetastatic / advanced

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

Researchers are looking for new ways to treat ovarian cancer (OC). Current treatment for OC may start with surgery to remove as much of the cancer as possible. After surgery, people may receive chemotherapy. After chemotherapy, standard care options may include: * Maintenance treatment, which is used after another therapy to keep the cancer from growing, spreading, or coming back. Bevacizumab is a targeted therapy used as standard maintenance treatment. Targeted therapy works to control how specific types of cancer cells grow and spread. * Observation, which is watching to see if cancer grows or worsens The study medicine, sacituzumab tirumotecan (also called sac-TMT), is a targeted therapy. The goal of this study is to learn if people who receive sac-TMT maintenance treatment with or without bevacizumab live longer without the cancer getting worse than people who receive standard care.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Choroba została potwierdzona badaniem tkanki.
  • Pacjent przeszedł operację usunięcia nowotworu.
  • Pacjent zakończył pierwszy etap leczenia chemioterapią.
  • Dostarczono tkankę guza, która nie była wcześniej naświetlana.
  • Jeśli pacjent ma HIV, choroba jest dobrze kontrolowana leczeniem.

✗ Disqualifies

  • Choroba jest innego rodzaju niż rak jajnika, otrzewnej lub jajowodu.
  • Choroba dała przerzuty do mózgu lub opon mózgowych.
  • Pacjent miał w przeszłości poważne problemy z oczami.
  • Pacjent ma problemy z jelitami wymagające leczenia lekami osłabiającymi odporność.
  • Pacjent przeszedł inne leczenie przeciwnowotworowe poza pierwszym etapem chemioterapii.
  • Pacjent miał w ostatnim czasie szczepionkę zawierającą żywe wirusy/bakterie.
  • Pacjent ma inną aktywnie postępującą chorobę nowotworową.
  • Pacjent ma aktywną infekcję wymagającą leczenia.

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
August 21, 2026
Sex
Female only

Therapies / drugs in trial

Locations (155)

University of Alabama - Birmingham ( Site 0058)

Birmingham, United States

John Muir Health Cancer Center ( Site 0069)

Walnut Creek, United States

Mount Sinai Cancer Center ( Site 0029)

Miami Beach, United States

Orlando Health Winnie Palmer Hospital for Women and Babies ( Site 0085)

Orlando, United States

Winship Cancer Institute of Emory University ( Site 0037)

Atlanta, United States

Illinois Cancer Specialists (ICS) ( Site 8009)

Arlington Heights, United States

Parkview Research Center at Parkview Regional Medical Center ( Site 0055)

Fort Wayne, United States

Women's Cancer Care ( Site 0018)

Covington, United States

Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc ( Site 0060)

Scarborough, United States

Maryland Oncology Hematology, P.A. ( Site 8002)

Columbia, United States

Nebraska Methodist Hospital ( Site 0004)

Omaha, United States

University Of Nebraska Medical Center ( Site 0035)

Omaha, United States

The Center of Hope ( Site 0025)

Reno, United States

Womens Cancer Care Associates, LLC ( Site 0023)

Albany, United States

Duke Cancer Center ( Site 0012)

Durham, United States

University of Cincinnati Medical Center ( Site 0042)

Cincinnati, United States

Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0007)

Tulsa, United States

Women & Infants Hospital ( Site 0001)

Providence, United States

West Cancer Center and Research Institute ( Site 0013)

Germantown, United States

University of Tennessee Medical Center ( Site 0087)

Knoxville, United States

Henry-Joyce Cancer Clinic ( Site 0011)

Nashville, United States

Virginia Cancer Specialists (VCS) ( Site 8012)

Fairfax, United States

Virginia Oncology Associates (VOA) ( Site 8013)

Norfolk, United States

Hospital Aleman ( Site 2903)

Ciudad Autonoma de Buenos Aires, Argentina

Instituto Alexander Fleming ( Site 2902)

Ciudad Autónoma de Buenos Aires, Argentina

Instituto de Investigaciones Clinicas Mar del Plata ( Site 2901)

Mar del Plata, Argentina

Fundación Respirar ( Site 2912)

Buenos Aires, Argentina

Sanatorio Parque - Oncología ( Site 2911)

Rosario, Argentina

Instituto de Oncologia de Rosario ( Site 2909)

Rosario, Argentina

Hospital Britanico de Buenos Aires ( Site 2905)

CABA, Argentina

Fundación CORI para la Investigación y Prevención del Cáncer ( Site 2907)

La Rioja, Argentina

Westmead Hospital ( Site 0201)

Westmead, Australia

Gallipoli Medical Research Ltd ( Site 0204)

Brisbane, Australia

Epworth Freemasons ( Site 0207)

East Melbourne, Australia

Medizinische Universitat Wien ( Site 0102)

Vienna, Austria

Medizinische Universitaet Innsbruck-Univ.-Klinik f. Gynäkologie und Geburtshilfe ( Site 0101)

Innsbruck, Austria

Grand Hopital de Charleroi ( Site 0303)

Charleroi, Belgium

AZ Maria Middelares ( Site 0302)

Ghent, Belgium

UZ Leuven ( Site 0301)

Leuven, Belgium

Obras Sociais Irma Dulce ( Site 0427)

Salvador, Brazil

Liga Norte Riograndense Contra o Cancer ( Site 0417)

Natal, Brazil

Hospital São Lucas da PUCRS ( Site 0415)

Porto Alegre, Brazil

ANIMI - Unidade de Tratamento Oncologico ( Site 0421)

Lages, Brazil

Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0414)

São José do Rio Preto, Brazil

CIUSSS - Saguenay-Lac-Saint-Jean ( Site 0519)

Chicoutimi, Canada

Centre Hospitalier de l'Université de Montréal ( Site 0518)

Montreal, Canada

McGill University Health Centre ( Site 0516)

Montreal, Canada

Clinica Puerto Montt ( Site 0606)

Port Montt, Chile

FALP ( Site 0607)

Santiago, Chile

Clínica Alemana de Santiago ( Site 0610)

Santiago, Chile

Pontificia Universidad Catolica de Chile ( Site 0602)

Santiago, Chile

ONCOCENTRO APYS-ACEREY ( Site 0603)

Viña del Mar, Chile

Fundacion Colombiana de Cancerología Clinica Vida ( Site 0803)

Medellín, Colombia

FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0801)

Bogotá, Colombia

Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 0802)

Valledupar, Colombia

Instituto Nacional De Cancerologia ( Site 0808)

Bogota, Colombia

Oncólogos del Occidente S.A.S. ( Site 0806)

Pereira, Colombia

Fakultni Nemocnice Brno Bohunice ( Site 3304)

Brno, Czechia

Fakultni nemocnice Ostrava-Gynekologicko-porodnicka klinika ( Site 3303)

Ostrava-Poruba, Czechia

Fakultni nemocnice Hradec Kralove ( Site 3307)

Hradec Králové, Czechia

Fakultni nemocnice Kralovske Vinohrady ( Site 3306)

Prague, Czechia

Vseobecna fakultni nemocnice v Praze ( Site 3305)

Prague, Czechia

Fakultni nemocnice motol ( Site 3302)

Prague, Czechia

Herlev Hospital ( Site 0902)

Herlev, Denmark

Aalborg Universitetshospital ( Site 0901)

Aalborg, Denmark

Aarhus Universitetshospital, Skejby ( Site 0903)

Aarhus, Denmark

Odense Universitets Hospital ( Site 0904)

Odense, Denmark

Oulun yliopistollinen sairaala ( Site 1003)

Oulu, Finland

Kuopion Yliopistollinen Sairaala ( Site 1004)

Kuopio, Finland

Tampereen yliopistollinen sairaala ( Site 1002)

Tampere, Finland

Turku University Hospital-Department of Obstetrics and Gynecology ( Site 1001)

Turku, Finland

CENTRE LEON BERARD ( Site 1101)

Lyon, France

Hopitaux Universitaires de Strasbourg ( Site 1109)

Strasbourg, France

Institut Paoli Calmettes ( Site 1111)

Marseille, France

Hôpital Privé Des Côtes d'Armor ( Site 1102)

Plérin, France

CHRU de Brest - Hopital de la Cavale Blanche ( Site 1104)

Brest, France

LBM ONCOPOLE CLAUDIUS REGAUD ( Site 1114)

Toulouse, France

Centre Hospitalier Universitaire Dupuytren ( Site 1112)

Limoges, France

Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau ( Site 1105)

Tours, France

Centre Oscar Lambret ( Site 1106)

Lille, France

Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne ( Site 1113)

Clermont-Ferrand, France

Alexandra General Hospital of Athens ( Site 0703)

Athens, Greece

Evgenidion Clinic Agia Trias S.A ( Site 0701)

Athens, Greece

Agios Loukas Clinic ( Site 0702)

Thessaloniki, Greece

Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 3910)

Kecskemét, Hungary

Petz Aladar Egyetemi Oktato Korhaz-Onkológiai Osztály ( Site 3911)

Győr, Hungary

Semmelweis Egyetem I. Szamu Szuleszeti es Nogyogyaszati Klinika ( Site 3915)

Budapest, Hungary

Országos Onkológiai Intézet-Ngyógyászat ( Site 3913)

Budapest, Hungary

Debreceni Egyetem Klinikai Kozpont-Szülészeti és Nőgyógyászati Klinika ( Site 3912)

Debrecen, Hungary

St James Hospital ( Site 1302)

Dublin, Ireland

Rambam Health Care Campus ( Site 1422)

Haifa, Israel

Edith Wolfson Medical Center ( Site 1423)

Holon, Israel

Sheba Medical Center ( Site 1421)

Ramat Gan, Israel

Azienda Ospedaliera Spedali Civili di Brescia ( Site 1501)

Brescia, Italy

ASST DI LECCO ( Site 1509)

Lecco, Italy

Istituto Nazionale dei Tumori ( Site 1504)

Milan, Italy

Istituto Europeo di Oncologia ( Site 1503)

Milan, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1510)

Roma, Italy

Ospedale Mauriziano ( Site 1507)

Torino, Italy

Kurume University Hospital ( Site 1615)

Kurume, Japan

Gunma Prefectural Cancer Center ( Site 1605)

Ōta, Japan

Hokkaido University Hospital ( Site 1609)

Sapporo, Japan

Hyogo Cancer Center ( Site 1620)

Akashi, Japan

Iwate Medical University Hospital ( Site 1610)

Shiwa-gun, Japan

Saitama Medical University International Medical Center ( Site 1607)

Hidaka, Japan

Shizuoka Cancer Center ( Site 1618)

Sunto-gun,, Japan

Cancer Institute Hospital of JFCR ( Site 1614)

Koto, Japan

Keio University Hospital ( Site 1611)

Shinjyuku, Japan

National Hospital Organization Kyushu Cancer Center ( Site 1603)

Fukuoka, Japan

Kagoshima City Hospital ( Site 1613)

Kagoshima, Japan

Niigata Cancer Center Hospital ( Site 1608)

Niigata, Japan

Okayama University Hospital ( Site 1619)

Okayama, Japan

Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 1604)

Osaka, Japan

Stavanger Universitetssjukehus ( Site 2002)

Stavanger, Norway

Sorlandet Sykehus Kristiansand ( Site 2003)

Kristiansand, Norway

Oslo University Hospital ( Site 2001)

Oslo, Norway

Clínica San Felipe ( Site 3603)

Lima, Peru

Uniwersytecki Szpital Kliniczny w Poznaniu-Oddzial Ginekologii Onkologicznej ( Site 2106)

Poznan, Poland

Wielkopolskie Centrum Onkologii im. Marii Skłodowskiej-Curie ( Site 2105)

Poznan, Poland

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2102)

Siedlce, Poland

Bialostockie Centrum Onkologii ( Site 2104)

Bialystok, Poland

Uniwersytecki Szpital Kliniczny nr2 PUM w Szczecinie ( Site 2103)

Szczecin, Poland

Severance Hospital ( Site 2302)

Seodaemun-Gu, South Korea

Keimyung University Dongsan Hospital ( Site 2304)

Daegu, South Korea

Seoul National University Hospital ( Site 2301)

Seoul, South Korea

Asan Medical Center ( Site 2305)

Seoul, South Korea

Samsung Medical Center ( Site 2303)

Seoul, South Korea

Institut Català d'Oncologia (ICO) - Girona ( Site 2402)

Girona, Spain

Complejo Hospitalario Universitario A Coruna ( Site 2412)

A Coruña, Spain

Clinica Universidad de Navarra ( Site 2407)

Madrid, Spain

Instituto Valenciano de Oncologia - IVO ( Site 2411)

Valencia, Spain

Hospital Vall D Hebron ( Site 2403)

Barcelona, Spain

Hospital Clinic I Provincial de Barcelona ( Site 2409)

Barcelona, Spain

ICO L Hospitalet ( Site 2408)

Barcelona, Spain

Hospital Universitario Reina Sofia ( Site 2406)

Córdoba, Spain

Hospital Ramon y Cajal ( Site 2405)

Madrid, Spain

Hospital Clinico San Carlos... ( Site 2410)

Madrid, Spain

Hospital Universitario La Paz-Oncología Médica ( Site 2404)

Madrid, Spain

Karolinska Universitetssjukhuset Solna ( Site 2502)

Stockholm, Sweden

Inselspital Bern ( Site 3504)

Bern, Switzerland

Ospedale Regionale Bellinzona e Valli ( Site 3501)

Bellinzona, Switzerland

Kantonsspital Graubünden ( Site 3503)

Chur, Switzerland

Hôpitaux Universitaires de Genève (HUG) ( Site 3502)

Geneva, Switzerland

Taichung Veterans General Hospital ( Site 2603)

Taichung, Taiwan

National Cheng Kung University Hospital ( Site 2602)

Tainan, Taiwan

National Taiwan University Hospital ( Site 2601)

Taipei, Taiwan

Mackay Memorial Hospital ( Site 2604)

Taipei, Taiwan

Linkou Chang Gung Memorial Hospital ( Site 2605)

Taoyuan, Taiwan

Ramathibodi Hospital. ( Site 3402)

Bangkok, Thailand

Faculty of Medicine Siriraj Hospital ( Site 3401)

Bangkoknoi, Thailand

Faculty of Medicine - Khon Kaen University ( Site 3403)

Muang, Thailand

Addenbrookes Hospital ( Site 2802)

Cambridge, United Kingdom

University Hospitals of Leicester NHS Trust ( Site 2805)

Leicester, United Kingdom

University College London Hospitals ( Site 2801)

London, United Kingdom

The Christie NHS Foundation Trust ( Site 2804)

Manchester, United Kingdom

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.